Literature DB >> 32476953

Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.

Arda Kiani1, Alireza Eslaminejad2, Mohsen Shafeipour3, Fatemeh Razavi2, Seyyed Reza Seyyedi4, Babak Sharif-Kashani4,5, Habib Emami5, Mehrdad Bakhshayesh-Karam6, Atefeh Abedini2.   

Abstract

Background: The 6-minute walking test, cardiopulmonary exercise testing, and spirometry are useful tools for evaluation of respiratory impairment and functional capacity in patients with lung disease. Sarcoidosis is a multisystem granulomatous disease of unknown etiology.
Objectives: Since the pulmonary involvement can affect the quality of life in sarcoidosis patients, this study is aimed to evaluate the tests mentioned above in order to examine the functional capacity of sarcoidosis patients in different stages as well as the cause of exercise intolerance.
Methods: This cross-sectional study was carried out on 50 Iranian patients with sarcoidosis. Patients were classified into three groups based on the findings of the chest radiography as well as the pulmonary CT scan, reported by an expert radiologist. Pulmonary, cardiac, and activity function have been evaluated in the patients, using cardiopulmonary exercise testing, the 6-minutes walking test, and spirometry.
Results: In cardiopulmonary exercise testing, percent-predicted peak VO2 (57.75±15.49, p=0.015) and percent-predicted O2 pulse (70.54±17.37, p=0.013) were significantly lower in the third group, in comparison with the others. Also, VE/CO2 (AT) (34.99±5.67, p=0.000) was significantly higher in the third group, in comparison with the other ones. Percent-predicted VO2 showed a strong positive correlation with age (r=0.377, p=0.009), TSH (r= 0.404, p=0.007), and percent-predicted FVC (r=0.443, p=0.002). In addition, O2 pulse had a positive correlation with BMI (r=0.324, p=0.026), percent-predicted FVC (r=0.557, p= 0.000), and percent-predicted FEV1 (r=0.316, p=0.032). Conclusions: According to this study, ventilatory limitation, pulmonary involvement, and deconditioning are the main causes of activity limitations in sarcoidosis patients. Copyright:
© 2020.

Entities:  

Keywords:  6-minute walk test; Cardiopulmonary exercise testing (D005080); Respiratory function tests (D012129); Sarcoidosis (D012507); Spirometry (D013147)

Mesh:

Year:  2019        PMID: 32476953      PMCID: PMC7247088          DOI: 10.36141/svdld.v36i3.7663

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  38 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis.

Authors:  K E Sietsema; M Kraft; L Ginzton; O P Sharma
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

3.  Prevalence of vitamin D deficiency among Iranian adolescents.

Authors:  Mehdi Ebrahimi; Patricia Khashayar; Abbasali Keshtkar; Koroush Etemad; Mahboubeh Dini; Zahra Mohammadi; Hossein Ebrahimi; Reza Chaman; Bagher Larijani
Journal:  J Pediatr Endocrinol Metab       Date:  2014-07       Impact factor: 1.634

4.  Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis.

Authors:  I Brådvik; P Wollmer; B Blom-Bülow; U Albrechtsson; B Jonson
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

5.  Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy.

Authors:  A Silverstein; L E Siltzbach
Journal:  Arch Neurol       Date:  1969-09

6.  Exercise and resting pulmonary function in sarcoidosis.

Authors:  M Karetzky; M McDonough
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1996-03       Impact factor: 0.670

7.  Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease.

Authors:  C Risk; G R Epler; E A Gaensler
Journal:  Chest       Date:  1984-01       Impact factor: 9.410

8.  Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?

Authors:  Rik G J Marcellis; Antoine F Lenssen; Geeuwke J de Vries; Robert P Baughman; Chris P van der Grinten; Johny A Verschakelen; Jolanda De Vries; Marjolein Drent
Journal:  Lung       Date:  2012-11-09       Impact factor: 2.584

9.  Association Between Vitamin D Deficiencies in Sarcoidosis with Disease Activity, Course of Disease and Stages of Lung Involvements.

Authors:  Arda Kiani; Atefeh Abedini; Ian M Adcock; Maryam Sadat Mirenayat; Kimia Taghavi; Esmaeil Mortaz; Mehdi Kazempour-Dizaji
Journal:  J Med Biochem       Date:  2018-04-01       Impact factor: 3.402

10.  Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.

Authors:  A J Lopes; S L S Menezes; C M Dias; J F Oliveira; M R M Mainenti; F S Guimarães
Journal:  Braz J Med Biol Res       Date:  2012-02-16       Impact factor: 2.590

View more
  2 in total

1.  Impulse Oscillometry as a measure of airway dysfunction in Sarcoidosis.

Authors:  Geetanjali Bade; Nasim Akhtar; Anjali Trivedi; Karan Madan; Randeep Guleria; Anjana Talwar
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-09-30       Impact factor: 0.670

2.  Value of Cardiopulmonary Exercise Testing in Prognostic Assessment of Patients with Interstitial Lung Diseases.

Authors:  Beate Stubbe; Till Ittermann; Anita Grieger; Charlotte Walther; Sven Gläser; Ralf Ewert
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.